{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:50Z","timestamp":1772165750604,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      One of the greatest success of pediatric hematology is a prominent improvement of survival in acute lymphoblastic leukemia (ALL\n                      <jats:italic>).<\/jats:italic>\n                      Therefore\n                      <jats:italic>,<\/jats:italic>\n                      special attention needs to be paid to long-term side effects of the treatment such as neurotoxicity. One of the few diagnostic methods that allow an objective assessment of sensory systems are evoked potentials (EP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The analyzed group consisted of 167 ALL long-term survivors, aged 4.9\u201328.4\u2009years, without auditory, visual and sensory deviations. Patients were treated with New York (NY,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200935), previous modified Berlin-Frankfurt-M\u00fcnster (pBFM,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200947) and BFM95 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200985) protocols. In order to assess the impact of radiotherapy on recorded EP, a joint analysis of NY and pBFM groups was performed. The control group consisted of 35 patients, aged 6\u201317\u2009years. The analyzed patients underwent a complex assessment with visual EP (VEP), somatosensory EP (SEP) and brainstem auditory EP (BAEP) in accordance with current standards.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      ALL treatment contributed to the shortening of wave I latency (1.59 vs 1.90,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003) and prolongation of I-III (2.23 vs 2.04,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004) and I-V (4.57 vs 4.24,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002) interwave latencies of BAEP. A significant effect was also noticed in P100 (106.32 vs 101.57,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and N135 (151.42 vs 138.22,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) latencies of VEP and N18 amplitude (3.24 vs 4.70,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007) and P25 latency (21.32 vs 23.39,\n                      <jats:italic>P\u2009&lt;<\/jats:italic>\n                      \u00a00.001) of SEP. The distribution of abnormalities between protocols was similar in BAEP (NY - 68.6%, pBFM - 61.7%, BFM95\u201369.4%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.650), VEP (NY - 68.6%, pBFM - 42.5%, BFM95\u201358.3%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.053) and significantly different for SEP (NY - 62.9%, pBFM - 36.2%, BFM95\u201353.0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.045). The harmful effect of radiotherapy was most clearly marked in numerous disturbances of SEP parameters.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The presented analysis indicates a high frequency of subclinical abnormalities in EP regardless of the analyzed protocol. To our knowledge current study is the largest and one of the most complex research examining the role of EP in ALL patients. The obtained results indicate the possibility of using a single, objective and non-invasive measurement of EP in ALL survivors in order to stratify the risk of developing sensory abnormalities in adulthood.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-07873-x","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T03:48:44Z","timestamp":1613015324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical utility of complex assessment with evoked potentials in acute lymphoblastic leukemia survivors: comparison of various treatment protocols"],"prefix":"10.1186","volume":"21","author":[{"given":"Slawomir","family":"Kroczka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Stepien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Witek-Motyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinga","family":"Kwiecinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eryk","family":"Kapusta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Biedron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Skorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6867-2717","authenticated-orcid":false,"given":"Szymon","family":"Skoczen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"7873_CR1","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda. https:\/\/seer.cancer.gov\/csr\/1975_2016\/. Accessed: 28 October 2019"},{"key":"7873_CR2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LAG, Dolya A, Bray F, Hesseling P, et al. International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol. 2017;18:719\u201331. https:\/\/doi.org\/10.1016\/S1470-2045(17)30186-9.","journal-title":"Lancet Oncol"},{"key":"7873_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.pcl.2014.11.003","volume":"62","author":"MB Clark-Gambelunghe","year":"2015","unstructured":"Clark-Gambelunghe MB, Clark DA. Sensory development. Pediatr Clin N Am. 2015;62:367\u201384. https:\/\/doi.org\/10.1016\/j.pcl.2014.11.003.","journal-title":"Pediatr Clin N Am"},{"key":"7873_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/13803395.2019.1623865","volume":"41","author":"KM Brace","year":"2019","unstructured":"Brace KM, Lee WW, Cole PD, Sussman ES. Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: a preliminary investigation. J Clin Exp Neuropsychol. 2019;41:814\u201331. https:\/\/doi.org\/10.1080\/13803395.2019.1623865.","journal-title":"J Clin Exp Neuropsychol"},{"key":"7873_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078599","volume":"8","author":"M Genschaft","year":"2013","unstructured":"Genschaft M, Huebner T, Plessow F, Ikonomidou VN, Abolmaali N, Krone F, et al. Impact of chemotherapy for childhood leukemia on brain morphology and function. PLoS One. 2013;8:e78599. https:\/\/doi.org\/10.1371\/journal.pone.0078599.","journal-title":"PLoS One"},{"key":"7873_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/s0385-8146(99)00074-7","volume":"27","author":"T Harada","year":"2000","unstructured":"Harada T, Namiki S, Kawabata I. Acute profound sensorineural hearing loss as the initial manifestation of acute leukemia--report of a case. Auris Nasus Larynx. 2000;27:359\u201362. https:\/\/doi.org\/10.1016\/s0385-8146(99)00074-7.","journal-title":"Auris Nasus Larynx"},{"key":"7873_CR7","doi-asserted-by":"publisher","first-page":"ii16","DOI":"10.1136\/jnnp.2005.068130","volume":"76","author":"P Walsh","year":"2005","unstructured":"Walsh P, Kane N, Butler S. The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry. 2005;76:ii16\u201322. https:\/\/doi.org\/10.1136\/jnnp.2005.068130.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7873_CR8","first-page":"1205","volume":"63","author":"S Kroczka","year":"2006","unstructured":"Kroczka S, Steczkowska-Klucznik M, Romaniszyn A. Auditory evoked potentials in patients after acute children's lymphoblastic leukemia treatment. Przegl Lek. 2006;63:1205\u20139.","journal-title":"Przegl Lek"},{"key":"7873_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00043426-198423000-00017","volume":"6","author":"TA Kaleita","year":"1984","unstructured":"Kaleita TA, Shields WD, Feig SA, Nuwer MR. Nervous system assessment with evoked potential tests in pediatric bone marrow transplant patients. Am J Pediatr Hematol Oncol. 1984;6:329\u201332.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"7873_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mpo.2950130603","volume":"13","author":"A Russo","year":"1985","unstructured":"Russo A, Tomarchio S, Pero G, Consoli G, Marina R, Rizzari C, et al. Abnormal visual-evoked potentials in leukemic children after cranial radiation. Med Pediatr Oncol. 1985;13:313\u20137. https:\/\/doi.org\/10.1002\/mpo.2950130603.","journal-title":"Med Pediatr Oncol"},{"key":"7873_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/1097-0142(19870301)59:5<891::aid-cncr2820590506>3.0.co;2-m","volume":"59","author":"H Muchi","year":"1987","unstructured":"Muchi H, Satoh T, Yamamoto K, Karube T, Miyao M. Studies on the assessment of neurotoxicity in children with acute lymphoblastic leukemia. Cancer. 1987;59:891\u20135. https:\/\/doi.org\/10.1002\/1097-0142(19870301)59:5<891::aid-cncr2820590506>3.0.co;2-m.","journal-title":"Cancer."},{"key":"7873_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/bf02072055","volume":"150","author":"R Korinthenberg","year":"1990","unstructured":"Korinthenberg R, Igel B. Prospective neurophysiological study in children treated for acute lymphoblastic leukaemia: serial EEG during treatment and long-term follow up with evoked potentials. Eur J Pediatr. 1990;150:127\u201331. https:\/\/doi.org\/10.1007\/bf02072055.","journal-title":"Eur J Pediatr"},{"key":"7873_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1055\/s-2007-973786","volume":"27","author":"MA Uberall","year":"1996","unstructured":"Uberall MA, Hertzberg H, Meier W, Langer T, Beck JD, Wenzel D. Visual-evoked potentials in long-term survivors of acute lymphoblastic leukemia in childhood. The German late effects working group. Neuropediatrics. 1996;27:194\u20136. https:\/\/doi.org\/10.1055\/s-2007-973786.","journal-title":"Neuropediatrics."},{"key":"7873_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s004310050700","volume":"156","author":"MA Ueberall","year":"1997","unstructured":"Ueberall MA, Skirl G, Strassburg HM, Wenzel D, Hertzberg H, Langer T, et al. Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A\/B. Eur J Pediatr. 1997;156:727\u201333. https:\/\/doi.org\/10.1007\/s004310050700.","journal-title":"Eur J Pediatr"},{"key":"7873_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0887-8994(95)00191-3","volume":"13","author":"L Vainionp\u00e4\u00e4","year":"1995","unstructured":"Vainionp\u00e4\u00e4 L, Kovala T, Tolonen U, Lanning M. Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve. Pediatr Neurol. 1995;13:314\u20138. https:\/\/doi.org\/10.1016\/0887-8994(95)00191-3.","journal-title":"Pediatr Neurol"},{"key":"7873_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/(sici)1096-911x(199701)28:1<41::aid-mpo8>3.0.co;2-t","volume":"28","author":"L Vainionp\u00e4\u00e4","year":"1997","unstructured":"Vainionp\u00e4\u00e4 L, Kovala T, Tolonen U, Lanning M. Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials. Med Pediatr Oncol. 1997;28:41\u20137. https:\/\/doi.org\/10.1002\/(sici)1096-911x(199701)28:1<41::aid-mpo8>3.0.co;2-t.","journal-title":"Med Pediatr Oncol"},{"key":"7873_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<200::AID-CNCR25>3.0.CO;2-5","volume":"82","author":"AH Harila-Saari","year":"1998","unstructured":"Harila-Saari AH, Vainionp\u00e4\u00e4 LK, Kovala TT, Tolonen EU, Lanning BM. Nerve lesions after therapy for childhood acute lymphoblastic leukemia. Cancer. 1998;82:200\u20137. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19980101)82:1<200::AID-CNCR25>3.0.CO;2-5.","journal-title":"Cancer."},{"key":"7873_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijporl.2006.09.001","volume":"71","author":"M Riga","year":"2007","unstructured":"Riga M, Psarommatis I, Korres S, Varvutsi M, Giotakis I, Apostolopoulos N, Ferekidis E. Neurotoxicity of vincristine on the medial olivocochlear bundle. Int J Pediatr Otorhinolaryngol. 2007;71:63.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"7873_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MAO.0b013e31802ce486","volume":"28","author":"M Riga","year":"2007","unstructured":"Riga M, Korres S, Psarommatis I, Varvutsi M, Giotakis I, Papadas T, Ferekidis E, Apostolopoulos N. Neurotoxicity of BFM-95 on the medial olivocochlear bundle assessed by means of contralateral suppression of 2f1-f2 distortion product otoacoustic emissions. Otol Neurotol. 2007;28:208.","journal-title":"Otol Neurotol"},{"key":"7873_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/bjc.1989.358","volume":"60","author":"J Tucker","year":"1989","unstructured":"Tucker J, Prior PF, Green CR, Ede GM, Stevenson JF, Gawler J, Jamal GA, Charlesworth M, Thakkar CM, Patel P. Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphoma. Br J Cancer. 1989;60:775.","journal-title":"Br J Cancer"},{"key":"7873_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mpo.2950140505","volume":"14","author":"NM Newman","year":"1986","unstructured":"Newman NM, Donaldson S, de Wit S, King O, Wilbur JR. Neuro-ocular damage in pediatric oncology patients: predictor of long-term visual disability or tool for limiting toxicity? Med Pediatr Oncol. 1986;14:262\u201370. https:\/\/doi.org\/10.1002\/mpo.2950140505.","journal-title":"Med Pediatr Oncol"},{"key":"7873_CR22","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archinternmed.2009.209","volume":"169","author":"LR Meacham","year":"2009","unstructured":"Meacham LR, Sklar CA, Li S, Liu Q, Gimpel N, Yasui Y, et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med. 2009;169:1381\u20138. https:\/\/doi.org\/10.1001\/archinternmed.2009.209.","journal-title":"Arch Intern Med"},{"key":"7873_CR23","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1158\/1055-9965.EPI-17-0510","volume":"26","author":"TM Gibson","year":"2017","unstructured":"Gibson TM, Li Z, Green DM, Armstrong GT, Mulrooney DA, Srivastava D, et al. Blood pressure status in adult survivors of childhood Cancer: a report from the St. Jude lifetime cohort study. Cancer Epidemiol Biomark Prev. 2017;26:1705\u201313. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-0510.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"7873_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3389\/fonc.2019.00230","volume":"9","author":"S Skoczen","year":"2019","unstructured":"Skoczen S, Stepien K, Krzysztofik M, Luszawska T, Hnatko-Kolacz M, Korostynski M, et al. Genetic profile and clinical implications of Hepatoblastoma and neuroblastoma coexistence in a child. Front Oncol. 2019;9:230. https:\/\/doi.org\/10.3389\/fonc.2019.00230.","journal-title":"Front Oncol"},{"key":"7873_CR25","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3389\/fonc.2019.01477","volume":"9","author":"S Skoczen","year":"2020","unstructured":"Skoczen S, Stepien K, Mlynarski W, Centkowski P, Kwiecinska K, Korostynski M, et al. Genetic signature of acute lymphoblastic leukemia and Netherton syndrome co-incidence \u2013 first report in the literature. Front Oncol. 2020;9:1477. https:\/\/doi.org\/10.3389\/fonc.2019.01477.","journal-title":"Front Oncol"},{"key":"7873_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3923\/pjbs.2010.527.536","volume":"13","author":"AA Tantawy","year":"2010","unstructured":"Tantawy AA, Hassanein SM, Adly AA, Saeed OM, Darwish YW, El Aziz AA. Somatosensory evoked potential for detection of subclinical neuropathy in Egyptian children with acute lymphoblastic leukaemia. Pak J Biol Sci. 2010;13:527\u201336. https:\/\/doi.org\/10.3923\/pjbs.2010.527.536.","journal-title":"Pak J Biol Sci"},{"issue":"54","key":"7873_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/pbc.28742","volume":"67","author":"S Kroczka","year":"2020","unstructured":"Kroczka S, Stepien K, Skoczen S. Clinical Utility of Complex Assessment With Evoked Potentials in Acute Lymphoblastic Survivors. Ped Blood Canc. 2020;67(54):362. https:\/\/doi.org\/10.1002\/pbc.28742.","journal-title":"Ped Blood Canc"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07873-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-021-07873-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-07873-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T03:52:17Z","timestamp":1613015537000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-07873-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7873"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-07873-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-61632\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"17 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was complied with the Declaration of Helsinki and was approved by the Jagiellonian University Medical College Ethics Committee (Consent No. KBET\/131\/B\/207). All parents, adolescent patients and adult patients signed written informed consent before inclusion in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}